About 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide
2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (PubChem CID 167661238) has the molecular formula C69H78F3N21O6
and a molecular weight of 1354.52 g/mol. Its IUPAC name is 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide.
Frequently Asked Questions
What is the IUPAC name of 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide?
The IUPAC name of 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (CID 167661238) is 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide.
What is the SMILES notation for 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide?
The canonical SMILES for 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide is CC(C)c1nc(-c2ccc(CC(=O)Nc3cc(C(C)(C)C)no3)cc2)c2c(N)ncnn12.CC(C)c1nc(-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c2c(N)ncnn12.CC(C)n1nc(-c2ccc(CC(=O)Nc3cc(C(C)(C)C(F)(F)F)no3)cc2)c2c(N)ncnc21.
What is the InChIKey of 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide?
The InChIKey is RZIHYIGQRMQYCF-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24F3N7O2.2C23H27N7O2/c1-12(2)33-21-18(20(27)28-11-29-21)19(31-33)14-7-5-13(6-8-14)9-16(34)30-17-10-15(32-35-17)22(3,4)23(24,25)26;1-13(2)22-28-19(20-21(24)25-12-26-30(20)22)15-8-6-14(7-9-15)10-18(31)27-17-11-16(32-29-17)23(3,4)5;1-13(2)22-28-19(20-21(24)25-12-26-30(20)22)15-8-6-14(7-9-15)10-17(31)27-18-11-16(29-32-18)23(3,4)5/h5-8,10-12H,9H2,1-4H3,(H,30,34)(H2,27,28,29);6-9,11-13H,10H2,1-5H3,(H2,24,25,26)(H,27,29,31);6-9,11-13H,10H2,1-5H3,(H,27,31)(H2,24,25,26).
What are the key properties of 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide?
2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide has a molecular weight of 1354.52 g/mol, XLogP of 12.59, 16 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide;2-[4-(4-amino-7-propan-2-ylimidazo[5,1-f][1,2,4]triazin-5-yl)phenyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)acetamide;2-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide is sourced from PubChem (CID 167661238), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).